A biotechnology company focused on developing small‑molecule therapies for cancer, particularly targeting the PI3K signaling pathway involved in hematologic malignancies. Its lead programs have included treatments for blood cancers such as leukemia and lymphoma, with development efforts centered on ...
1 member of Congress has disclosed 1 trade in Infinity Pharmaceuticals, Inc. (INFI), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2017-10-12 | Roger W. Marshall | buy | $1K – $15K |